|
1
|
Elkouby-Naor L and Ben-Yosef T: Functions
of claudin tight junction proteins and their complex interactions
in various physiological systems. Int Rev Cell Mol Biol. 279:1–32.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tsukita S, Furuse M and Itoh M:
Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol.
2:285–293. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Matter K, Aijaz S, Tsapara A and Balda MS:
Mammalian tight junctions in the regulation of epithelial
differentiation and proliferation. Curr Opin Cell Biol. 17:453–458.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
González-Mariscal L, Betanzos A, Nava P
and Jaramillo BE: Tight junction proteins. Prog Biophys Mol Biol.
81:1–44. 2003.
|
|
5
|
Takahashi A, Kondoh M, Kodaka M and Yagi
K: Peptides as tight junction modulators. Curr Pharm Des.
17:2699–2703. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lee KW, Lee NK, Kim JH, et al: Twist1
causes the transcriptional repression of claudin-4 with prognostic
significance in esophageal cancer. Biochem Biophys Res Commun.
423:454–460. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tokés AM, Kulka J, Paku S, et al:
Claudin-1, -3, and -4 proteins and mRNA expression in benign and
malignant breast lesions: a research study. Breast Cancer Res.
7:R296–R305. 2005.PubMed/NCBI
|
|
8
|
Miyamori H, Takino T, Kobayashi Y, Tokai
H, Itoh Y, Seiki M and Sato H: Claudin promotes activation of
pro-matrix metalloproteinase-2 mediated by membrane-type matrix
metalloproteinases. J Biol Chem. 276:28204–28211. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Turksen K and Troy TC: Junctions gone bad:
claudins and loss of the barrier in cancer. Biochim Biophys Acta.
1816:73–79. 2011.PubMed/NCBI
|
|
10
|
Quan C and Lu SJ: Identification of genes
preferentially expressed in mammary epithelial cells of Copenhagen
rat using subtractive hybridization and microarrays.
Carcinogenesis. 24:1593–1599. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wu Q, Liu Y, Ren Y, Xu X, Yu L, Li Y and
Quan C: Tight junction protein, claudin-6, downregulates the
malignant phenotype of breast carcinoma. Eur J Cancer Prev.
19:186–194. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hui L, Bakiri L, Stepniak E and Wagner EF:
p38alpha: a suppressor of cell proliferation and tumorigenesis.
Cell Cycle. 6:2429–2433. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Green JA, Dholakia S, Friedland JS, et al:
Mycobacterium tuberculosis-infected human monocytes down-regulate
microglial MMP-2 secretion in CNS tuberculosis via TNFα, NFκB, p38
and caspase 8 dependent pathways. J Neuroinflammation.
8:462011.PubMed/NCBI
|
|
14
|
Kim ES, Kim MS and Moon A:
TGF-beta-induced upregulation of MMP-2 and MMP-9 depends on p38
MAPK, but not ERK signaling in MCF10A human breast epithelial
cells. Int J Oncol. 25:1375–1382. 2004.PubMed/NCBI
|
|
15
|
Hazan RB, Qiao R, Keren R, Badano I and
Suyama K: Cadherin switch in tumor progression. Ann NY Acad Sci.
1014:155–163. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jordan NV, Johnson GL and Abell AN:
Tracking the intermediate stages of epithelial-mesenchymal
transition in epithelial stem cells and cancer. Cell Cycle.
10:2865–2873. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bhat AA, Sharma A, Pope J, Krishnan M,
Washington MK, Singh AB and Dhawan P: Caudal homeobox protein cdx-2
cooperates with Wnt pathway to regulate claudin-1 expression in
colon cancer cells. PLoS One. 7:e371742012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Neesse A, Griesmann H, Gress TM and Michl
P: Claudin-4 as therapeutic target in cancer. Arch Biochem Biophys.
524:64–70. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lambert D, Padfield PJ, McLaughlin J,
Cannell S and O’Neill CA: Ochratoxin A displaces claudins from
detergent resistant membrane microdomains. Biochem Biophys Res
Commun. 358:632–636. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Haorah J, Heilman D, Persidsky Y, et al:
Ethanol-induced activation of myosin light chain kinase leads to
dysfunction of tight junctions and blood-brain barrier compromise.
Alcohol Clin Exp Res. 29:999–1009. 2005. View Article : Google Scholar
|
|
21
|
Oshima T, Miwa H and Joh T: Aspirin
induces gastric epithelial barrier dysfunction by activating p38
MAPK via claudin-7. Am J Physiol Cell Physiol. 295:C800–C806. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li Q, Zhu F and Chen P: miR-7 and miR-218
epigenetically control tumor suppressor genes RASSF1A and Claudin-6
by targeting HoxB3 in breast cancer. Biochem Biophys Res Commun.
424:28–33. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sun C, Yi T, Song X, et al: Efficient
inhibition of ovarian cancer by short hairpin RNA targeting
claudin-3. Oncol Rep. 26:193–200. 2011.PubMed/NCBI
|
|
24
|
Hui L, Bakiri L, Mairhorfer A, et al:
p38alpha suppresses normal and cancer cell proliferation by
antagonizing the JNK-c-Jun pathway. Nat Genet. 39:741–749. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Perdiguero E, Ruiz-Bonilla V, Gresh L, et
al: Genetic analysis of p38 MAP kinases in myogenesis: fundamental
role of p38alpha in abrogating myoblast proliferation. EMBO J.
26:1245–1256. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ventura JJ, Tenbaum S, Perdiguero E, Huth
M, Guerra C, Barbacid M, Pasparakis M and Nebreda AR: p38alpha MAP
kinase is essential in lung stem and progenitor cell proliferation
and differentiation. Nat Genet. 39:750–758. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bulavin DV and Fornace AJ Jr: p38 MAP
kinase’s emerging role as a tumor suppressor. Adv Cancer Res.
92:95–118. 2004.
|
|
28
|
Lee B, Kim CH and Moon SK: Honokiol causes
the p21WAF1-mediated G(1)-phase arrest of the cell cycle through
inducing p38 mitogen activated protein kinase in vascular smooth
muscle cells. FEBS Lett. 580:5177–5184. 2006. View Article : Google Scholar
|
|
29
|
Takehara M, Nishimura T, Mima S, Hoshino T
and Mizushima T: Effect of claudin expression on paracellular
permeability, migration and invasion of colonic cancer cells. Biol
Pharm Bull. 32:825–831. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ikari A, Takiguchi A, Atomi K, Sato T and
Sugatani J: Decrease in claudin-2 expression enhances cell
migration in renal epithelial Madin-Darby canine kidney cells. J
Cell Physiol. 226:1471–1478. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Osanai M, Murata M, Chiba H, Kojima T and
Sawada N: Epigenetic silencing of claudin-6 promotes
anchorage-independent growth of breast carcinoma cells. Cancer Sci.
98:1557–1562. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Agarwal R, D’Souza T and Morin PJ:
Claudin-3 and claudin-4 expression in ovarian epithelial cells
enhances invasion and is associated with increased matrix
metalloproteinase-2 activity. Cancer Res. 65:7378–7385. 2005.
View Article : Google Scholar : PubMed/NCBI
|
